Team that sold Auris Health to J & J for nearly $6B raises $300M in 'blank check' IPO

A "blank check" company led by Silicon Valley robotic surgery entrepreneurs and investors is poised to begin trading on Wall Street Tuesday after raising $300 million in an IPO. The special purpose acquisition company, Lux Health Tech Acquisition Corp. (NASDAQ:LUXAU), plans to find a health tech company to merge with and take public. It's led by Peter Hebert, co-founder and managing director of Menlo Park-based Lux Ventures, and Josh DeFonzo, the former president of John son& Johnson's robotics …
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news